This website is for UK healthcare professionals and UK healthcare decision makers only

Reporting adverse events
A
A
Prescribing information for:

Ferinject 
(ferric carboxymaltose)

Kapruvia ▼
(difelikefalin)

Tavneos ▼
(avacopan)

Veltassa 
(patiromer)

Venofer 
(iron sucrose)

Key information on chronic kidney disease-associated
pruritus (CKD-aP), including the disease itself, how it
impacts patients, and why managing it is important

FERINJECT®
(ferric carboxymaltose)

KAPRUVIA®(difelikefalin)

TAVNEOS®(avacopan)

VELTASSA®
(patiromer)

WEBINARS
AND EVENTS

WHAT IS CKD-aP?

Explore all aspects of the disease, from symptoms and pathophysiology to prevalence in the UK

Symptom Burden of CKD-ap

Find out how CKD-aP is affecting the lives of patients on HD and the impact on sleep and QoL

Increasing awareness of
CKD-aP

Find out why CKD-aP is under-diagnosed and under-reported

 

CKD-aP, chronic kidney disease-associated pruritus; HCP, healthcare professional;  HD, haemodialysis; QoL, quality of life.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Vifor Pharma UK Ltd. (Tel 01276 853633). Email: medicalinfo_UK@viforpharma.com
More Resources

Ferinject

Resources

Veltassa

Resources

You are now heading to a third-party website that we do
not operate. We are not responsible for the content of the
third-party website. You are advised to review its privacy policy
as it may differ from ours.

 

Are you sure you want to leave?

Confirm

Cancel

Report adverse events in the UK:

Adverse events should be reported. Reporting forms and information for United Kingdom can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Vifor Pharma Ltd. Tel: +44 1276 853633. E-mail: medicalInfo_UK@viforpharma.com